Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Protein, antibody developer reports net loss of $73.2M for 2005
March 2nd, 2006
CuraGen Corp. (CRGN) reported its consolidated financial results for the fourth quarter and fiscal year ended December 31, 2005. For the year ended December 31, 2005, CuraGen's consolidated net loss was $73.2 million, or $1.41 per share, compared to a net loss of $90.4 million, or $1.81 per share, for fiscal year 2004. The net loss for the fourth quarter of 2005 was $15.6 million, or $0.29 per share, compared to a net loss of $22.7 million, or $0.45 per share, in the fourth quarter of 2004. As of December 31, 2005, CuraGen had available cash and investments of $226.5 million, and had outstanding 6% convertible debt of $66.2 million, due February...
Source: Women's Health Weekly (2006-03-02)
|
